Direct Compression of Afatinib Tablets
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current manufacturing processes for Afatinib dimaleate tablets are complex, require specific equipment, and have low yields, making them unsuitable for large-scale production and cost-effective production while ensuring adequate hardness, disintegration time, dissolution profiles, and storage stability.
Innovation Solution
A direct compression process for producing tablets of Afatinib or its pharmaceutically acceptable salts, specifically utilizing crystalline forms A to M of Afatinib dimaleate, which allows for a simple, single-step, cost-effective method that maintains the required pharmaceutical properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If dry granulation via roller compaction is used to manufacture Afatinib tablets, then adequate tablet hardness and disintegration time can be achieved, but the process becomes complex, requires specific equipment, and yields are lower
Solution Approach 1:
The invention extracts and eliminates the intermediate granulation step from the manufacturing process. By using direct compression technology, the complex roller compaction equipment and multi-step process are removed, while still achieving the required tablet hardness and disintegration characteristics through optimized compression parameters and formulation composition.
Solution Approach 2:
The invention replaces the mechanical roller compaction system with a direct compression system. Instead of using roller compressors to form granules first, the tablet press directly compresses the powder mixture into final tablets, substituting a complex mechanical granulation system with a simpler direct compression approach that achieves equivalent product quality.
2Reliability
If dry granulation via roller compaction is used to manufacture Afatinib tablets, then adequate tablet properties can be achieved, but the manufacturing cost increases and losses during manufacturing are higher
Solution Approach 1:
The invention merges the granulation and tableting operations into a single direct compression step. By combining what were previously separate processes (granulation followed by tableting) into one operation, manufacturing complexity and cost are reduced, while yield is improved by eliminating material losses associated with the intermediate granulation step.
Solution Approach 2:
The invention enables the powder mixture to self-compress into tablets with adequate hardness and disintegration properties through optimized compression force and formulation design. The material itself provides the necessary binding and structural properties during direct compression, eliminating the need for external granulation assistance and reducing manufacturing costs.
3Ease of manufacture
If direct compression is used to manufacture Afatinib tablets, then the process becomes simple and cost-effective, but it must maintain adequate hardness, disintegration time, dissolution profiles, and storage stability
Solution Approach 1:
The invention optimizes critical parameters including compression force, particle size distribution, moisture content, and formulation composition to enable direct compression to produce tablets meeting all quality specifications. By carefully controlling these parameters, the simplified direct compression process achieves equivalent hardness, disintegration time, dissolution profiles, and storage stability compared to the complex roller compaction method.
Data Source
AI summary
The present invention relates to a tablet comprising Afatinib or a pharmaceutically acceptable salt thereof, wherein the tablet is obtained by direct compression. The present invention further relates to a process for manufacturing a tablet of the invention as well as the use of the tablet of the invention.